Research grant to study Lewy body disease
Press release issued: 20 September 2011
Researchers at the University of Bristol’s Dementia Research Group have been awarded a grant by local charity BRACE to investigate Lewy body disease and its association with other diseases, such as Alzheimer’s and Parkinson’s.
Lewy body disease is a form of dementia that shares characteristics with both Alzheimer’s and Parkinson’s diseases.
In Parkinson’s disease (PD) nerve cells form Lewy bodies, aggregates of the protein α-synuclein. Lewy body formation is initiated by the addition of phosphate to α-synuclein. Some variants of PD cause dementia and the brains of those patients usually accumulate Aβ, also found in Alzheimer’s disease (AD).
Seth Love, Professor of Neuropathology in the University’s School of Clinical Sciences, who will be leading the project, said: “This grant will help us to learn more about Lewy body disease and its association with other diseases and should help in the treatment of the disease.
“There is a lot of evidence to indicate that the Aβ exacerbates the dementia-associated variants of PD but the mechanism remains unclear.”
Mark Poarch, Chief Executive of BRACE, added: “The announcement of this project is a reminder that Alzheimer’s is not the only form of dementia that causes suffering to a great many people. BRACE exists to fight dementia through medical science, and we are able to do so because of the fantastic support of local people over the past 24 years. With their continued support, we can help to win this fight.”
Experimental studies suggest that some forms of Aβ may cause the addition of phosphate to α-synuclein, producing Lewy bodies and nerve cell damage. At present, the levels of the different forms of Aβ (some of which are dissolved and not visible in tissue sections) that accumulate in the brain in PD or its variants are not known.
The study aims to measure the levels of the different forms of Aβ in the brain in these variants of PD, and the researchers will conduct studies to find out whether Lewy body formation and the toxicity of α-synuclein to nerve cells are increased by the Aβ.
Further informationThe Dementia Research Group, headed by Professor Seth Love and Dr Patrick Kehoe, is focused on the molecular epidemiology and pathogenesis of Alzheimer’s disease and related dementias. The Group’s research programme translates a number of interwoven research themes using molecular genetic, biochemical, cell culture-based and neuropathological approaches to the study of dementia. The research group is part of the University of Bristol’s School of Clinical Sciences and is based in the John James Laboratories at Frenchay Hospital.
BRACE is a registered charity (No. 297965) established in 1987 to finance research into conditions of the elderly, particularly Alzheimer's disease. BRACE supports research projects undertaken in universities and hospitals in the South West of the UK, particularly in Bristol, which is a centre of excellence for neuroscience research.
BRACE has raised more than £12 million to help support diverse research projects into all aspects of dementia.
BRACE is one of only a few charities that exist specifically to finance dementia research - this work is vital if future generations are to be free from the fear of this devastating illness.